Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.

NACompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

May 31, 2010

Conditions
Ovarian Cancer
Interventions
BEHAVIORAL

Individualised follow-up

Patients allocated to gynaecological cancer nurse specialist at the end of primary treatment. Follow-up is negotiated to suit their individual situation. Type of contact is flexible, primarily by telephone although some women may opt for face-to-face appointments. Patients will be assessed using a holistic guide to identify signs of disease progression, symptoms warranting intervention, and psychological issues. The nurses delivering the intervention are expert in the management of ovarian cancer and will work to a model of health promoting interactions oriented towards improving self-efficacy. The nurses will provide information and support to assist patients to manage troublesome symptoms and live with psychological discomfort.

Trial Locations (3)

SS0 0RY

Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea

SS16 5NL

Basildon & Thurrock University Hospitals NHS Foundation Trust, Basildon

NW1 2BU

University College London Hospital NHS Foundation Trust, London

All Listed Sponsors
collaborator

University College London Hospitals

OTHER

collaborator

Mid and South Essex NHS Foundation Trust

OTHER

lead

University College, London

OTHER

NCT02298855 - Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer. | Biotech Hunter | Biotech Hunter